HK Stock MarketDetailed Quotes

02096 SIMCERE PHARMA

Watchlist
  • 5.150
  • -0.040-0.77%
Market Closed Apr 19 16:08 CST
13.44BMarket Cap17.05P/E (TTM)

About SIMCERE PHARMA Company

Xiansheng Pharmaceutical (2096.HK) is a pharmaceutical company driven by innovation and R&D, and has a “National Key Laboratory for Neurological and Oncology Drug Development”. The company focuses on the fields of oncology, the nervous system, autoimmunity and anti-infection, and at the same time actively proactively lays out future disease fields with significant clinical needs, and is committed to enabling patients to use more effective drugs as soon as possible. Driven by independent research and development and collaborative innovation, the company has established strategic partnerships with many innovative enterprises and research institutes.

Company Profile

Symbol02096
Company NameSIMCERE PHARMA
ISINHK0000658531
Listing DateOct 27, 2020
Issue Price13.70
Shares Offered260.57M share(s)
FoundedNov 30, 2015
Registered AddressHong Kong, China
Chairmanjinsheng ren
Secretarybaowenwanyushan mai
Audit InstitutionKPMG
Company CategoryOverseas registration of Mainland Individuals control
Registered OfficeRoom 703, 7th floor, Building 20E, Phase III, Hong Kong Science Park, Shatin, New Territories, Hong Kong
Head Office and Principal Place of BusinessRoom 703, 7th floor, Building 20E, Phase III, Hong Kong Science Park, Shatin, New Territories, Hong Kong
Fiscal Year Ends12-31
Employees7027
MarketHong Kong motherboard
Phone86(25)85566366
Fax(025)85262330
Emailir@simcere.com
Websitehttp://www.simcere.com
Business The company focuses on the fields of oncology, the nervous system, autoimmunity and anti-infection, and at the same time actively proactively lays out future disease fields with significant clinical needs, and is committed to enabling patients to use more effective drugs as soon as possible.

Company Executives

  • Name
  • Position
  • Salary
  • jinsheng ren
  • CEOs，Chairman，Executive Director，Chairman of the Strategy Committee，Remuneration Committee Members，Nomination Committee Members
  • --
  • yushan wan
  • chief financial officer，Executive Director，Joint Company Secretary，Board Secretary，Remuneration Committee Members，Authorized Representative
  • --
  • renhong tang
  • Executive Vice President，senior vice president，Chairman and CEO of Xiansheng Zaiming，Executive Director，Strategy Committee Members，Authorized Representative
  • --
  • xi wang
  • VP，Executive Director，Nomination Committee Members
  • --
  • ruilin song
  • Independent Non-Executive Director，Chairman of the Nomination Committee，Audit Committee Members
  • --
  • jianguo wang
  • Independent Non-Executive Director，Remuneration Committee Chairman，Audit Committee Members，Strategy Committee Members，Nomination Committee Members
  • --
  • xinhua wang
  • Independent Non-Executive Director，Chairman of the Audit Committee，Remuneration Committee Members
  • --
  • Kevin Oliver
  • senior vice president
  • --
  • jiahuan song
  • Independent Non-Executive Director，Nomination Committee Members，Remuneration Committee Members
  • --
  • Bijoyesh Mookerjee
  • Chief Medical Officer of Oncology
  • --
  • xianghua cheng
  • VP
  • --
  • gaobo zhou
  • Chief Investment Officer
  • --
  • haibo qian
  • VP
  • --
  • Tamas Oravecz
  • senior vice president，Chief Scientific Officer of Pioneer America
  • --
  • ruiwen shi
  • VP
  • --
  • tong zhu
  • senior vice president
  • --
  • feng wang
  • VP
  • --
  • Danny Chen
  • senior vice president
  • --
  • baowen mai
  • Joint Company Secretary
  • --
  • wenjie song
  • Senior Vice President of Xiansheng Zaiming Pharmaceutical Co., Ltd.
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg